Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FSY83
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,565
Award facts
- Contract value 100% obligated
- $25,564.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Alecensa 150 mg capsules (240-count units) with a ceiling value of $25.6K. This delivery order, which carries no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The award represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA, valued at $500M through November 2026, which enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities nationwide.
This delivery order exemplifies the contractor's established role as a critical supplier within the federal pharmaceutical supply chain. DMS Pharmaceutical Group has demonstrated consistent success in competing for pharmaceutical procurement opportunities with the DLA, leveraging its woman-owned small business status and comprehensive inventory of branded and generic prescription drugs, specialty medications, and medical consumables. The Alecensa order fulfills the Defense Department's ongoing need for oncology and specialty pharmaceutical products to support military health system requirements across installations worldwide.
Quick answers
Who was awarded contract SPE2DB25FSY83?
SPE2DB25FSY83 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FSY83 worth?
The government has obligated $25,565 on SPE2DB25FSY83.
Is contract SPE2DB25FSY83 an order under another contract?
Yes. SPE2DB25FSY83 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSY83 competed?
The extent of competition for SPE2DB25FSY83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award